Amilo-5MER (TFA)
Amilo-5MER (5-MP) TFA is an orally active and selective Serum Amyloid A (SAA) inhibitor. Amilo-5MER TFA specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells. Amilo-5MER TFA reduces chronic inflammation and relieves symptoms of diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS) . Amilo-5MER TFA is promising for research of autoimmune diseases and chronic inflammatory diseases[1].
Product Specifications
Product Name Alternative
5-MP (TFA)
UNSPSC
12352209
Target
Amyloid-β; Interleukin Related
Related Pathways
Immunology/Inflammation; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Inflammation/Immunology
Purity
99.63
Solubility
0.1 M Acetic acid : 0.5 mg/mL (ultrasonic) |DMSO : 25 mg/mL (ultrasonic)
Smiles
CC(C)[C@@H](C(N)=O)NC([C@H](CC(O)=O)NC([C@H](C)NC([C@H]([C@H](O)C)NC([C@@H](NC(C)=O)CCSC)=O)=O)=O)=O.O=C(C(F)(F)F)O.[x]
Molecular Formula
C23H40N6O9S.xC2HF3O2
Molecular Weight
576.66 (free base)
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
